Physician profile
Michael Rabice
NPI 1235195769
$1,778.38
in general payments reported to CMS, 2019-2025
7 companies · $313 in 2025
The $313 reported for 2025 was more than what 85% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $15.77 · 2021: $37.94 · 2022: $512 · 2023: $215 · 2024: $364 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $830 · Food and Beverage: $61.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $830.00 |
| Food and Beverage | $61.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sekisui Diagnostics LLC | $1,305.00 | 2022-2025 | |
| Biofire Diagnostics, LLC | $300.00 | 2019 | |
| Merck Sharp & Dohme LLC | $65.72 | 2020-2022 | |
| Pfizer INC. | $39.08 | 2023-2024 | |
| Sanofi Pasteur INC. | $24.80 | 2021 | |
| Alk-Abello, INC | $22.73 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $21.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rabice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.